Ampio Pharmaceuticals, Inc. (NYSE:AMPE) was the target of a significant increase in short interest in October. As of October 31st, there was short interest totalling 5,074,976 shares, an increase of 19.0% from the October 13th total of 4,264,623 shares. Approximately 7.4% of the company’s shares are sold short. Based on an average trading volume of 1,355,536 shares, the short-interest ratio is presently 3.7 days.

Shares of Ampio Pharmaceuticals (NYSE AMPE) opened at $1.24 on Tuesday. Ampio Pharmaceuticals has a fifty-two week low of $0.38 and a fifty-two week high of $1.34.

ILLEGAL ACTIVITY WARNING: “Short Interest in Ampio Pharmaceuticals, Inc. (AMPE) Expands By 19.0%” was originally reported by American Banking News and is the property of of American Banking News. If you are reading this piece on another domain, it was illegally stolen and republished in violation of US and international copyright legislation. The original version of this piece can be accessed at

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company’s two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema.

Receive News & Ratings for Ampio Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals Inc. and related companies with's FREE daily email newsletter.